A bill to address pharmaceutical access, costs and transparency. Imposes new transparency requirements on pharmaceutical manufacturers and PBMs.

A bill to address pharmaceutical access, costs and transparency. Imposes new transparency requirements on pharmaceutical manufacturers and PBMs.

An Act limiting facility fees

An Act to protect health care consumers from surprise billing

An Act to ensure effective health care as a right. The center for health information and analysis shall recommend a methodology to develop a single payer benchmark. The single payer health care system considered under the single payer benchmark shall offer continuous, comprehensive and affordable coverage for all residents of the commonwealth regardless of income, assets, health status or availability of other health coverage. The benchmark may consider the costs of a single-payer health care system at different actuarial values, levels of cost-sharing and levels of provider reimbursement; provided however that the benchmark shall include all actuarial values, levels of cost-sharing and levels of provider reimbursement considered by the center. In developing the methodology, the center shall monitor, review and evaluate reports related to single payer health care and the performance of single payer health care systems in other states and countries.

An Act relative to pharmaceutical gag clauses relative to contracts for pharmacy services between health insurance carriers or pharmacy benefits’ managers and pharmacies or pharmacists.

An Act relative to pharmaceutical gag clauses relative to contracts for pharmacy services between health insurance carriers or pharmacy benefits’ managers and pharmacies or pharmacists.